RT Journal Article
SR Electronic
T1 <em>NLRC5</em> germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007255
DO 10.1136/jitc-2023-007255
VO 11
IS 6
A1 Meng, Xiang-Yu
YR 2023
UL http://jitc.bmj.com/content/11/6/e007255.abstract